Ensign Peak Advisors, Inc
- SEC CIK
- 0001454984
- Latest filing
- Aug 14, 2026
AVIR holding history
Atea Pharmaceuticals, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVIR overviewAll 13F holders of AVIRFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −84,030−100.0% | Sold out | Holders |
| Q2 2023 | 84,030 | $314.3K | <0.1% | +15,550+22.7% | Added | Holders |
| Q1 2023 | 68,480 | $229.4K | <0.1% | +19,500+39.8% | Added | Holders |
| Q4 2022 | 48,980 | $235.6K | <0.1% | +19,200+64.5% | Added | Holders |
| Q3 2022 | 29,780 | $169.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 29,780 | $211.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 29,780 | $215.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 29,780 | $266.0K | <0.1% | +29,780 | New | Holders |